3 Results
Guidelines and Advice
Status: Current
ID: GL #4-4v2
Version: 2
ID: GL #4-4v2
Version: 2
Sep 2020
Drug
Jan 2022
Guidelines and Advice
Status: In-Review
ID: GL 2-33
ID: GL 2-33
Jun 2022